Sermorelin 5mg

Sermorelin 5mg

Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary gland to produce more natural Growth Hormone. It’s used for anti-aging, recovery, sleep quality and body composition.

Apply for a Trade Account

SEQUORA Sermorelin 5mg is a synthetic peptide that mimics part of the body’s growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release growth hormone, which helps regulate growth, tissue maintenance and metabolism. It’s used as a performance peptide to aid with endurance, muscle growth and anti-aging.

Choose your product format
  • 5mg vial: a 5mg sealed vial of lyophilized powder (freeze dried). This format extends the shelf-life significantly and also allows freezer storage of your Sermorelin. This vial can then be mixed with Bacteriostatic Water (BAC water) and be used as an injectable Sermorelin.
  • 5mg prefilled pen: A prepared reconstituted Sermorelin in a 3ml cartridge. This is then inserted into a SEQUORA disposable injector pen for easy use and dosing.

The 5mg figure indicates the total stated content across all three compounds, not the concentration or amount delivered per withdrawal. Review the specifications for your selected format.

Purity & Verification

All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.

What is Sermorelin 5mg used For?

SEQUORA TB-500 & BPC-157 aka the Wolverine Stack is used for recovery and repair in muscles, joints, ligaments and tendons. Whether you’ve had an injury through physical exercise or an accident, the Wolverine Stack

What are the benefits of Sermorelin 5mg?

GLOW by SEQUORA is known to boost skin vitality, aid with injury and tendon/ligament damage repair . It is used by both men and women for it’s longevity boosting benefits and body recovery.

Why buy Sermorelin 5mg from SEQUORA?

SEQUORA’s GLOW blend is accurately dosed, providing 50mg of GHK-Cu, 10mg of BPC 157 and 10mg of TB-500 . We test all of our peptides for purity but also accurate dosing which can be found in the SEQUORA GLOW test summary.

Questions & Answers

What Is the GLOW Peptide Blend & Whats in it?

SEQUORA GLOW is a product name for an injectable blend of three peptides: GHK-Cu, BPC-157, and TB-500. The name GLOW is commonly used by most clinics and vendors for the same trio, and each ingredient is a separate compound with its own research history.

KLOW is GLOW plus KPV, which makes it a four-peptide blend. KPV is a short peptide that the FDA lists among substances nominated for compounding, and its regulatory story is covered in the status section below. The other three ingredients are identical in both products.

KPV’s main benefit is inflammation battling properties, so if this isn’t something you’re looking to treat or suffer with, then GLOW will have the same benefits as KLOW at a smaller price point.

Why are both GLOW and KLOW Blue in Colour?

GLOW’s characteristic blue colour comes from GHK-Cu, the copper peptide in the blend. GHK is a three-amino-acid peptide that binds to a copper ion. This complex absorbs certain wavelengths of visible light, giving it its blue appearance.

SEQUORA GLOW contains 50mg of GHK-Cu within its 70mg peptide blend, making it approximately 71% of the stated peptide content. BPC-157 and TB-500 do not normally contribute a blue colour.

The freeze-dried powder may appear pale blue, while a dissolved solution can look clear blue. Its appearance varies with concentration, formulation and lighting.

Side effects come from clinical trials and patient studies and are not confirmed medically. Injection site reactions are the most frequent as that’s a normal reaction to GHK-Cu and mild sensitivity or soreness around the injection site.

  • Anyone with a copper sensitivity or Wilson Disease should not use GLOW.
  • Anyone with active cancer or a recent cancer history should not use GLOW down to several of its components acting on blood vessel growth and cell migration.
  • ibuprofen, naproxen, and aspirin all conflict with the protocol, including the versions hiding inside cold and headache combination products.

Product Information Guide

Wolverine Stack

Product information, handling and safety

Storage

What Temperature should I store my Wolverine Stack at?

Safety

What are the best practices for using Wolverine Stack safely?

Evidence

The documentation behind Wolverine Stack and it's uses

What is Wolverine Stack?

Sermorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates your pituitary gland to produce more natural Growth Hormone. It’s used for anti-aging, recovery, sleep quality and body composition.

Storage & Handling

Storage

Upon delivery store in a refridgerator between 2-8°C.

  • Avoid storing at the very back of the refridgerator.
  • Avoid exposure to heat, direct sunlight and temperature fluctuations.
  • Never freeze your SEQUORA Sermorelin Pens (Vials are safe to be frozen BEFORE reconstitution only).

Handling

Avoid dropping or heavy-handling of your Sermorelin Blend.

Please do not freeze your SEQUORA Sermorelin Pen as this can compromise the peptide.

Your product has been shipped in secure packaging to prevent any potential issues however if you believe your peptides have been compromised contact us directly.

shelf-life

Your SEQUORA Sermorelin Pen will last 12 months from the date of manufacture providing you follow the storage instructions provided.

SEQUORA Sermorelin Vials before reconstitution can last up to 4 years at -5°C

Sermorelin can be kept at room temperature however it’s shelf life when held at this temperature reduces to 1-2 months.

Safety & Hygiene

pre-use hygiene

Before handling your Sermorelin, needles or injection material, ensure your research area is clean and clear.

Wash your hands with warm water and soap and allow to dry fully before handling any SEQUORA products to prevent cross contamination or infection risks.

If at any point the cleanliness of your injection or environment is compromised, restart this step.

needle & injection safety

Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.

Before using your SEQUORA Sermorelin Pen, using an alcohol swab, wipe the tip of the cartridge after removing the lid to the pen.

If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.

post-injection guidance

Ensure that your needle tips, syringes and vials are safely disposed of post-use.

This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.

Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.

Potential Wolverine Stack Side Effects

Sermorelin can cause unwanted reactions. Potential injection-site reactions, flushing, headache and dizziness. Personal reports also describe changes in sleep and alertness, but these accounts cannot establish how frequently symptoms occur or whether sermorelin caused them.

Recognised side effects

  • Pain, redness, irritation or swelling at the injection site
  • Facial flushing or a sensation of warmth
  • Headache
  • Dizziness or lightheadedness
  • Sleepiness
  • Nausea

Sleep and next-day alertness

Some people describing prescribed sermorelin use report disrupted sleep, unusually heavy sleep or prolonged morning grogginess. Others report improved sleep. These contrasting experiences mean that better sleep should not be assumed and significant daytime impairment should be reviewed.

Puffy hands, feet or other swelling

New swelling requires medical assessment. It may reflect fluid retention or another medical problem and should not automatically be attributed to increasing the dose too quickly.

Sudden swelling of the face, lips, tongue or throat is different from gradual puffiness and may indicate a serious allergic reaction.

Allergic reactions

Possible warning signs include widespread itching, hives, a severe rash, facial swelling or difficulty breathing or swallowing. Personal reports describe reactions after both initial exposure and previous uneventful use. Prior tolerance does not guarantee that a future administration will be safe.

When to contact a medical professional

Seek prompt advice for persistent headaches, recurrent dizziness, new hand or foot swelling, troublesome sleep changes or marked daytime sleepiness. These symptoms warrant review of the treatment and other possible causes rather than an automatic dose adjustment.

Symptoms requiring urgent help

Stop administration and call 999 for difficulty breathing, swelling of the tongue or throat, chest pain or collapse. Sudden facial swelling with widespread hives or breathing symptoms also requires emergency help.

Seek urgent medical advice for widespread hives or a severe rash even without breathing symptoms. A sudden severe headache, headache with visual changes or new weakness also requires urgent assessment.

Wolverine Stack Side Effect Mitigation

Side-effect management should be guided by a medical professional.

Persistent headache

  • Do not increase the dose while headaches are being assessed.
  • Record when the headache starts, its severity and its relationship to administration.
  • Contact your prescriber before further dosing if headaches persist, recur or become more severe.
  • Do not repeatedly mask symptoms with painkillers to continue treatment without review.

Seek urgent assessment for a sudden severe headache, visual changes, vomiting or neurological symptoms.

Dizziness or lightheadedness

  • Sit or lie down safely until symptoms settle.
  • Avoid driving, exercise or hazardous activities while affected.
  • Report recurrent symptoms and share any available blood-pressure readings with your clinician.
  • Do not assume dizziness is harmless or simply evidence that the dose increased too quickly.

Puffy hands or feet

  • Contact your prescriber before further dosing if new swelling develops.
  • Record whether swelling affects one or both sides and whether there is associated pain, numbness or rapid weight change.
  • Do not self-treat with diuretics, excessive water intake or other hormone medicines.
  • Seek urgent help if swelling accompanies breathlessness or chest pain.

Sleep disruption or morning grogginess

  • Keep a brief record of administration time, sleep quality and next-day alertness.
  • Discuss persistent problems with your prescriber rather than assuming they will resolve.
  • A clinician may reconsider the amount, timing or treatment itself. Personal reports of improvement after changes do not establish a universal solution.
  • Do not add sedatives, alcohol or stimulants to counter unwanted effects.

Injection-site irritation

  • Follow the injection technique and site-rotation instructions provided by your clinical team.
  • Do not inject into skin that is already inflamed, bruised or damaged.
  • Seek assessment for spreading redness, increasing pain, warmth, discharge or fever.
  • Do not change the diluent or concentration to troubleshoot a reaction without advice from the dispensing pharmacist.

Hives, severe rash or suspected allergy

Stop use and seek urgent medical advice. Do not restart at a lower dose, switch batches or take an antihistamine simply to enable another administration. A reaction can develop despite previous uneventful use.

Call 999 for breathing difficulty, tongue or throat swelling, chest pain or collapse. If you have a prescribed adrenaline auto-injector, follow your emergency allergy plan and call 999.

Dosing Guidance For Sermorelin 5mg

Sermorelin is a peptide best used over a long duration, named a “course”. The calculations below are based on the SEQUORA 5mg Sermorelin Pen, reconstituted in 3ml of BAC Water.

Beginner Dosing Protocol

DOSE SCHEDULE PEN DIAL NUMBER WEEKLY TOTAL
100 mcg 5 nights per week 6 500 mcg
200 mcg 5 nights per week 12 1,000 mcg

Duration and progression

3 months, beginning with 100 mcg for the first two weeks before increasing to 200 mcg.

Understanding the figures

Setting 6 delivers 0.06 ml containing 100 mcg. Setting 12 delivers 0.12 ml containing 200 mcg. Settings apply to each administration, not the weekly total.

Intermediate Dosing Protocol

DOSE SCHEDULE PEN DIAL NUMBER WEEKLY TOTAL
200 mcg 5 nights per week 12 1,000 mcg
300 mcg 5 nights per week 18 1,500 mcg

Duration and progression

3–6 months, start on the lower end of the dose at 200 mcg and increase steadily across months 3-4 up to 300 mcg

Understanding the figures

Setting 12 delivers 0.12 ml containing 200 mcg. Setting 18 delivers 0.18 ml containing 300 mcg. Settings apply to each administration, not the weekly total.

Advanced Dosing Protocol

DOSE SCHEDULE PEN DIAL NUMBER WEEKLY TOTAL
300 mcg 5–7 nights per week 18 1,500–2,100 mcg
500 mcg 5–7 nights per week 30 2,500–3,500 mcg

Duration and progression

4–6 months. start on the lower end of the dose at 300 mcg and increase steadily across months 3-4 up to 500 mcg

Understanding the figures

Setting 18 delivers 0.18 ml containing 300 mcg. Setting 30 delivers 0.30 ml containing 500 mcg. Weekly totals vary with the number of administrations.

Important Information

  • Do not double the next amount to compensate. Sermorelin works pulse by pulse, so a bigger dose cannot make up a missed one.
  • he beginner and intermediate examples use five administration nights and two rest nights. The advanced example allows five to seven nights. These are alternatives, not a ladder to progress through.
  • Try to administer your subcutaneous injection 30–60 minutes before bed, at least one hour after eating, with no food for 30 minutes afterwards.